Reproducibility of metabolic measurements in malignant tumors using FDG PET.
暂无分享,去创建一个
M Schwaiger | M. Schwaiger | S. Ziegler | W. Weber | S. Ziegler | A. Hanauske | R. Thödtmann | W A Weber | S I Ziegler | R Thödtmann | A R Hanauske | M. Schwaiger | Wolfgang A. Weber
[1] G van Kaick,et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] E. Rota Kops,et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] M Schwaiger,et al. Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. , 1998, Blood.
[4] M Schwaiger,et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] R L Wahl,et al. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] R L Wahl,et al. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] E Bellon,et al. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. , 1998, International journal of radiation oncology, biology, physics.
[8] M Schwaiger,et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. , 1996, Journal of the National Cancer Institute.
[9] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] R L Wahl,et al. Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. , 1995, Radiology.
[11] Heikki Joensuu,et al. Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors , 1988 .
[12] Y. Yonekura,et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] O. Hoekstra,et al. Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] G. van Kaick,et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] J. Bergh,et al. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] G Y Gillespie,et al. Computerized tomography brain scan tumor volume determinations. Sensitivity as an objective criterion of response to therapy. , 1990, Journal of neurosurgery.
[17] H. Minn,et al. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma , 1994, Cancer.
[18] R. Lufkin,et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. , 1993, Radiology.
[19] J M Hoffman,et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[20] E. Van Cutsem,et al. Size quantification of liver metastases in patients undergoing cancer treatment: reproducibility of one-, two-, and three-dimensional measurements determined with spiral CT. , 1997, Radiology.
[21] T. Momose,et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] U Ruotsalainen,et al. Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] L M Hamberg,et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] G van Kaick,et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[25] T Ido,et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] G. Leroux-Roels,et al. Laboratory Assessment of Five Glucose Meters Designed for Self-Monitoring of Blood Glucose Concentration , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.